Evenity

Active Ingredient(s): Romosozumab-aqqg
FDA Approved: * April 9, 2019
Pharm Company: * AMGEN INC
Category: Osteoporosis

Romosozumab, sold under the brand name Evenity, is a medication used to treat osteoporosis.[1] It has been found to decrease the risk of fractures of the spine.[1] Common side effect include headache, joint pain, and pain at the site of injection.[1] It may increase the risk of heart attacks, strokes, and deaths from cardiovascular disease.[1] It is a humanized monoclonal antibody that targets sclerostin.[2] Rese... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Evenity 105 mg/1.17ml Subcutaneous Injection, Solution
NDC: 55513-880
Labeler:
Amgen Inc